United Kingdom· GB-APID-3057311000001100
Proctofoam HC foam enema
A medicinal product containing hydrocortisone + pramocaine, registered in United Kingdom by Meda Pharmaceuticals Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Hydrocortisone + Pramocaine
- Manufacturer
- Meda Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin7317510000264
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hydrocortisone + pramocaine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/28ec1133-674b-44ee-9619-2895c4dadecf GET /v1/drugs/28ec1133-674b-44ee-9619-2895c4dadecf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "3057311000001100",
"desc": "Proctofoam HC foam enema (Meda Pharmaceuticals Ltd)",
"form": "Rectal foam",
"vpid": "36056611000001102",
"source": "dmd",
"vtm_id": "776259007",
"strength": "10 mg",
"substance": "Hydrocortisone + Pramocaine",
"ingredient": "Hydrocortisone acetate",
"supplier_code": "3312911000001106"
}See everything about hydrocortisone + pramocaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.